Zobrazeno 1 - 10 of 144 pro vyhledávání: '"Asari, I."'
1
Akademický článek
Low Serum IL-18 Levels May Predict the Effectiveness of Dupilumab in Severe Asthma.
Autor: Watanabe S; Clinical Research Center, National Hospital Organization Tokyo National Hospital, Japan.; Department of Respiratory Medicine, The University of Tokyo, Japan., Suzukawa M; Clinical Research Center, National Hospital Organization Tokyo National Hospital, Japan.; Asthma, Allergy and Rheumatology Center, National Hospital Organization Tokyo National Hospital, Japan., Tashimo H; Asthma, Allergy and Rheumatology Center, National Hospital Organization Tokyo National Hospital, Japan., Ohshima N; Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Japan., Asari I; Clinical Research Center, National Hospital Organization Tokyo National Hospital, Japan., Takada K; Clinical Research Center, National Hospital Organization Tokyo National Hospital, Japan.; Department of Geriatric Medicine, The University of Tokyo, Japan., Imoto S; Clinical Research Center, National Hospital Organization Tokyo National Hospital, Japan.; Department of Respiratory Medicine, The University of Tokyo, Japan., Nagase T; Department of Respiratory Medicine, The University of Tokyo, Japan., Ohta K; Department of Respiratory Medicine, The University of Tokyo, Japan.; Department of Respiratory Medicine, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Japan.
Publikováno v: Internal medicine (Tokyo, Japan) [Intern Med] 2024 Jan 15; Vol. 63 (2), pp. 179-187. Date of Electronic Publication: 2023 May 24.
Zobrazit plný text záznamu
2
Akademický článek
Leptin-producing monocytes in the airway submucosa may contribute to asthma pathogenesis.
Autor: Watanabe K; National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Kiyose-City, Tokyo 204-8585, Japan; Department of Respiratory Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan., Suzukawa M; National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Kiyose-City, Tokyo 204-8585, Japan. Electronic address: fueta-tky@umin.ac.jp., Kawauchi-Watanabe S; National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Kiyose-City, Tokyo 204-8585, Japan; Department of Respiratory Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan., Igarashi S; National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Kiyose-City, Tokyo 204-8585, Japan., Asari I; National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Kiyose-City, Tokyo 204-8585, Japan., Imoto S; National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Kiyose-City, Tokyo 204-8585, Japan; Department of Respiratory Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan., Tashimo H; National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Kiyose-City, Tokyo 204-8585, Japan., Fukami T; National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Kiyose-City, Tokyo 204-8585, Japan., Hebisawa A; National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Kiyose-City, Tokyo 204-8585, Japan; Department of Histopathology, Asahi General Hospital, I-1326, Asahi City, Chiba 289-2511, Japan., Tohma S; National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Kiyose-City, Tokyo 204-8585, Japan., Nagase T; Department of Respiratory Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan., Ohta K; National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Kiyose-City, Tokyo 204-8585, Japan; Japan Anti-Tuberculosis Association, Fukujuji Hospital, 3-1-24 Matsuyama, Kiyose-City, Tokyo 204-8522, Japan.
Publikováno v: Respiratory investigation [Respir Investig] 2023 Jan; Vol. 61 (1), pp. 5-15. Date of Electronic Publication: 2022 Nov 09.
Zobrazit plný text záznamu
3
Akademický článek
High serum cytokine levels may predict the responsiveness of patients with severe asthma to benralizumab.
Autor: Watanabe S; Clinical Research Center, National Hospital Organization Tokyo National Hospital, Tokyo, Japan.; Department of Respiratory Medicine, University of Tokyo, Tokyo, Japan., Suzukawa M; Clinical Research Center, National Hospital Organization Tokyo National Hospital, Tokyo, Japan.; Asthma, Allergy and Rheumatology Center, National Hospital Organization Tokyo National Hospital, Tokyo, Japan., Tashimo H; Asthma, Allergy and Rheumatology Center, National Hospital Organization Tokyo National Hospital, Tokyo, Japan., Ohshima N; Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Tokyo, Japan., Asari I; Clinical Research Center, National Hospital Organization Tokyo National Hospital, Tokyo, Japan., Imoto S; Clinical Research Center, National Hospital Organization Tokyo National Hospital, Tokyo, Japan.; Department of Respiratory Medicine, University of Tokyo, Tokyo, Japan., Kobayashi N; Asthma, Allergy and Rheumatology Center, National Hospital Organization Tokyo National Hospital, Tokyo, Japan., Tohma S; Asthma, Allergy and Rheumatology Center, National Hospital Organization Tokyo National Hospital, Tokyo, Japan., Nagase T; Department of Respiratory Medicine, University of Tokyo, Tokyo, Japan., Ohta K; Asthma, Allergy and Rheumatology Center, National Hospital Organization Tokyo National Hospital, Tokyo, Japan.; Department of Respiratory Medicine, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Tokyo, Japan.
Publikováno v: The Journal of asthma : official journal of the Association for the Care of Asthma [J Asthma] 2022 Aug; Vol. 59 (8), pp. 1604-1612. Date of Electronic Publication: 2021 Jul 01.
Zobrazit plný text záznamu
4
Akademický článek
Evaluation of cytokine levels in response to mitogen among HIV-1-infected blood cells and their relationships to the number of T cells.
Autor: Imoto S; National Hospital Organization Tokyo National Hospital, Tokyo 204-8585, Japan; Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan., Suzukawa M; National Hospital Organization Tokyo National Hospital, Tokyo 204-8585, Japan. Electronic address: fueta-tky@outlook.jp., Takeda K; National Hospital Organization Tokyo National Hospital, Tokyo 204-8585, Japan., Asari I; National Hospital Organization Tokyo National Hospital, Tokyo 204-8585, Japan., Watanabe S; National Hospital Organization Tokyo National Hospital, Tokyo 204-8585, Japan; Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan., Tohma S; National Hospital Organization Tokyo National Hospital, Tokyo 204-8585, Japan., Nagase T; Department of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan., Ohta K; National Hospital Organization Tokyo National Hospital, Tokyo 204-8585, Japan; Japan Anti-Tuberculosis Association, Fukujuji Hospital, Tokyo 193-0834, Japan., Teruya K; National Center for Global Health and Medicine, Tokyo 162-8655, Japan., Nagai H; National Hospital Organization Tokyo National Hospital, Tokyo 204-8585, Japan.
Publikováno v: Cytokine [Cytokine] 2022 May; Vol. 153, pp. 155840. Date of Electronic Publication: 2022 Mar 08.
Zobrazit plný text záznamu
5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
7
Akademický článek
IL-1RA in the supernatant of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus is useful for discriminating active tuberculosis from latent infection.
Autor: Akashi S; Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Tokyo, Japan; Shin-Yurigaoka General Hospital, Tokyo, Japan., Suzukawa M; Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Tokyo, Japan. Electronic address: fueta-tky@umin.ac.jp., Takeda K; Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Tokyo, Japan; Department of Basic Mycobacteriology, Graduate School of Biomedical Science, Nagasaki University, Nagasaki, Japan., Asari I; Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Tokyo, Japan., Kawashima M; Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Tokyo, Japan., Ohshima N; Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Tokyo, Japan., Inoue E; Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Tokyo, Japan., Sato R; Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Tokyo, Japan., Shimada M; Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Tokyo, Japan., Suzuki J; Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Tokyo, Japan., Yamane A; Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Tokyo, Japan., Tamura A; Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Tokyo, Japan., Ohta K; Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Tokyo, Japan; Japan Anti-Tuberculosis Association, Fukujuji Hospital, Tokyo, Japan., Tohma S; Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Tokyo, Japan., Teruya K; National Center for Global Health and Medicine, Tokyo, Japan., Nagai H; Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Tokyo, Japan.
Publikováno v: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2021 Apr; Vol. 27 (4), pp. 617-624. Date of Electronic Publication: 2020 Dec 11.
Zobrazit plný text záznamu
8
Akademický článek
A Low Serum CCL4/MIP-1β Level May Predict a Severe Asthmatic Responsiveness to Mepolizumab.
Autor: Suzukawa M; Asthma, Allergy and Rheumatology Center, National Hospital Organization Tokyo National Hospital, Japan.; Clinical Research Center, National Hospital Organization Tokyo National Hospital, Japan., Ohshima N; Center for Pulmonary Diseases, National Hospital Organization Tokyo National Hospital, Japan., Tashimo H; Asthma, Allergy and Rheumatology Center, National Hospital Organization Tokyo National Hospital, Japan., Asari I; Clinical Research Center, National Hospital Organization Tokyo National Hospital, Japan., Kobayashi N; Asthma, Allergy and Rheumatology Center, National Hospital Organization Tokyo National Hospital, Japan., Shoji S; Asthma, Allergy and Rheumatology Center, National Hospital Organization Tokyo National Hospital, Japan., Tohma S; Asthma, Allergy and Rheumatology Center, National Hospital Organization Tokyo National Hospital, Japan., Ohta K; Asthma, Allergy and Rheumatology Center, National Hospital Organization Tokyo National Hospital, Japan.; Clinical Research Center, National Hospital Organization Tokyo National Hospital, Japan.; Department of Respiratory Medicine, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Japan.
Publikováno v: Internal medicine (Tokyo, Japan) [Intern Med] 2020 Nov 15; Vol. 59 (22), pp. 2849-2855. Date of Electronic Publication: 2020 Jul 21.
Zobrazit plný text záznamu
9
Akademický článek
Evaluation of cytokine levels using QuantiFERON-TB Gold Plus in patients with active tuberculosis.
Autor: Suzukawa M; Clinical Research Center, National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Kiyose-City, Tokyo 204-8585, Japan. Electronic address: fueta-tky@umin.ac.jp., Takeda K; Clinical Research Center, National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Kiyose-City, Tokyo 204-8585, Japan; Department of Basic Mycobacteriology, Graduate School of Biomedical Science, Nagasaki University, 1-14 Bunkyomachi, Nagasaki, 852-8521, Japan., Akashi S; Clinical Research Center, National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Kiyose-City, Tokyo 204-8585, Japan., Asari I; Clinical Research Center, National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Kiyose-City, Tokyo 204-8585, Japan., Kawashima M; Clinical Research Center, National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Kiyose-City, Tokyo 204-8585, Japan., Ohshima N; Clinical Research Center, National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Kiyose-City, Tokyo 204-8585, Japan., Inoue E; Clinical Research Center, National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Kiyose-City, Tokyo 204-8585, Japan., Sato R; Clinical Research Center, National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Kiyose-City, Tokyo 204-8585, Japan., Shimada M; Clinical Research Center, National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Kiyose-City, Tokyo 204-8585, Japan., Suzuki J; Clinical Research Center, National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Kiyose-City, Tokyo 204-8585, Japan., Yamane A; Clinical Research Center, National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Kiyose-City, Tokyo 204-8585, Japan., Tamura A; Clinical Research Center, National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Kiyose-City, Tokyo 204-8585, Japan., Ohta K; Clinical Research Center, National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Kiyose-City, Tokyo 204-8585, Japan; Japan Anti-Tuberculosis Association, Fukujuji Hospital, Tokyo, Japan., Tohma S; Clinical Research Center, National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Kiyose-City, Tokyo 204-8585, Japan., Teruya K; National Center for Global Health and Medicine, Tokyo, Japan., Nagai H; Clinical Research Center, National Hospital Organization Tokyo National Hospital, 3-1-1 Takeoka, Kiyose-City, Tokyo 204-8585, Japan.
Publikováno v: The Journal of infection [J Infect] 2020 May; Vol. 80 (5), pp. 547-553. Date of Electronic Publication: 2020 Feb 22.
Zobrazit plný text záznamu
10
Editorial & Opinion
Expression of Siglec-8 is regulated by interleukin-5, and serum levels of soluble Siglec-8 may predict responsiveness of severe eosinophilic asthma to mepolizumab.
Autor: Arakawa S; National Hospital Organization, Tokyo National Hospital, Tokyo, Japan; Department of Respiratory Medicine, University of Tokyo, Tokyo, Japan., Suzukawa M; National Hospital Organization, Tokyo National Hospital, Tokyo, Japan. Electronic address: fueta-tky@umin.ac.jp., Ohshima N; National Hospital Organization, Tokyo National Hospital, Tokyo, Japan., Tashimo H; National Hospital Organization, Tokyo National Hospital, Tokyo, Japan., Asari I; National Hospital Organization, Tokyo National Hospital, Tokyo, Japan., Matsui H; National Hospital Organization, Tokyo National Hospital, Tokyo, Japan., Kobayashi N; National Hospital Organization, Tokyo National Hospital, Tokyo, Japan., Shoji S; National Hospital Organization, Tokyo National Hospital, Tokyo, Japan., Nagase T; Department of Respiratory Medicine, University of Tokyo, Tokyo, Japan., Ohta K; National Hospital Organization, Tokyo National Hospital, Tokyo, Japan.
Publikováno v: Allergology international : official journal of the Japanese Society of Allergology [Allergol Int] 2018 Sep; Vol. 67S, pp. S41-S44. Date of Electronic Publication: 2018 Apr 24.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje